Niki BioSolutions, Inc. (NIKI) Cash from Financing Activities (2017 - 2025)
Niki BioSolutions' (NIKI) quarterly Cash from Financing Activities came in at $100000.0 in Q4 2025, little changed YoY from $100000.0 in Q4 2024, and down 33.33% on a QoQ basis from $150000.0 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) Cash from Financing Activities (2017 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 3 years of Cash from Financing Activities data on file, last reported at $100000.0 in Q4 2025.
- Quarterly Cash from Financing Activities changed 0.0% year-over-year to $100000.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $450000.0 (changed N/A YoY) and the FY2025 annual result came in at $4.4 million, changed N/A from the prior year.
- Cash from Financing Activities slipped to $100000.0 in Q4 2025, from $150000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $150000.0 in Q3 2025 to a low of $100000.0 in Q3 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 100,000.00 |
| Nov 30, 2025 | 100,000.00 |
| Aug 31, 2025 | 150,000.00 |
| Aug 31, 2025 | 150,000.00 |
| Nov 30, 2024 | 100,000.00 |
| Nov 30, 2024 | 100,000.00 |
| Aug 31, 2024 | 100,000.00 |
| Aug 31, 2024 | 100,000.00 |
| Dec 31, 2017 | 9.08 Mn |
| Dec 31, 2017 | 9.08 Mn |